MSD's Bold HIV Drug Combo: Could It Be the Future of Treatment?MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent expiration.
Elon Musk's Neuralink Hits Milestone: Second Patient Gets Brain ChipElon Musk announced that Neuralink successfully implanted its own developed computer chip into the brain of a second patient.
World Head and Neck Cancer Day: Why Tongue Cancer Should Be on Your RadarTo mark World Head and Neck Cancer Day, which falls this Sunday, we explored tongue cancer with insights with Professor Han Seung Hoon.
Could Your Dinner Be Making Your Allergies Worse? What to Avoid!As temperatures fluctuate dramatically, allergies such as rhinitis are becoming more severe. Despite ...
Elon Musk's Neuralink Enrolls Three Patients For Its Clinical TrialNeuralink, Elon Musk's brain chip company, announced that three participants will evaluate its device in a study expected to take a few years.
First Recipient of Pig Kidney Transplant Passes Away: Mass. General Hospital ConfirmsA man in his 60s who received a genetically modified pig kidney transplant in the U.S. last March ha ...
New Hope for Non-Hodgkin's Lymphoma Patients: Verismo's SynKIR-310 Enters Clinical Trial PhaseVerismo Therapeutics, a U.S. subsidiary of HLB developing next-generation CAR-T cell therapies, announced on the 5th that it has submitted a Phase 1 clinical trial plan (IND) to the U.S. Food and Drug Administration (FDA) for SynKIR-310, a treatment for recurrent/refractory non-Hodgkin’s lymphoma. The clinical trial will target patients with various types of lymphoma, including […]
Why Young Americans Can't Kick the Spicy, Sweet, and Salty HabitThe number of gout patients, a disease known to be so painful that even a light breeze can cause tremendous pain, is steadily rising. The number of young gout patients in their 20s and 30s, in particular, is rapidly increasing. According to the Health Insurance Review and Assessment Service, the number of patients in their […]
Patient Struggles with Blindness After Receiving Eye SurgeryMan loses sight after cosmetic eye surgery in Gangnam; hospital claims it's a "common symptom" post-surgery.
Must-Reads
1
What’s Next for Nissan’s Iconic GT-R? The Hyper Force Concept Gives Us a Glimpse
BUSINESS
2
Tesla's Self-Driving Technology's Horrible Flaw: Self-Driving Vehicle on the Railroad Tracks
DEBATE
3
Tesla's Invasion of Privacy: Controversy Arises Over Sensitive Driver Data Sharing
DEBATE
4
North Korea Sends Young Volunteers to Dangerous Jobs Under the Guise of Voluntary Participation
ASIA
5
Tension Soars in South Korea’s Presidential Security: Arming Guards with Heavy Weapons After Resignation
MSD's Bold HIV Drug Combo: Could It Be the Future of Treatment? MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent expiration.
Elon Musk's Neuralink Hits Milestone: Second Patient Gets Brain Chip Elon Musk announced that Neuralink successfully implanted its own developed computer chip into the brain of a second patient.
World Head and Neck Cancer Day: Why Tongue Cancer Should Be on Your Radar To mark World Head and Neck Cancer Day, which falls this Sunday, we explored tongue cancer with insights with Professor Han Seung Hoon.
Could Your Dinner Be Making Your Allergies Worse? What to Avoid! As temperatures fluctuate dramatically, allergies such as rhinitis are becoming more severe. Despite ...
Elon Musk's Neuralink Enrolls Three Patients For Its Clinical Trial Neuralink, Elon Musk's brain chip company, announced that three participants will evaluate its device in a study expected to take a few years.
First Recipient of Pig Kidney Transplant Passes Away: Mass. General Hospital Confirms A man in his 60s who received a genetically modified pig kidney transplant in the U.S. last March ha ...
New Hope for Non-Hodgkin's Lymphoma Patients: Verismo's SynKIR-310 Enters Clinical Trial Phase Verismo Therapeutics, a U.S. subsidiary of HLB developing next-generation CAR-T cell therapies, announced on the 5th that it has submitted a Phase 1 clinical trial plan (IND) to the U.S. Food and Drug Administration (FDA) for SynKIR-310, a treatment for recurrent/refractory non-Hodgkin’s lymphoma. The clinical trial will target patients with various types of lymphoma, including […]
Why Young Americans Can't Kick the Spicy, Sweet, and Salty Habit The number of gout patients, a disease known to be so painful that even a light breeze can cause tremendous pain, is steadily rising. The number of young gout patients in their 20s and 30s, in particular, is rapidly increasing. According to the Health Insurance Review and Assessment Service, the number of patients in their […]
Patient Struggles with Blindness After Receiving Eye Surgery Man loses sight after cosmetic eye surgery in Gangnam; hospital claims it's a "common symptom" post-surgery.
Hot Topics